Check-Cap to Participate in the Oppenheimer 16th Annual Israeli Conference on May 10, 2015 in Tel Aviv

ISFIYA, Israel, May 4, 2015 /PRNewswire/ -- Check-Cap, Ltd. (Nasdaq: CHEK, CHEKW) a clinical stage medical diagnostics company engaged in the development of a preparation-free ingestible imaging capsule screening for colorectal cancer, announced today that Guy Neev, Chief Executive Officer, will participate in the medical devices panel at the Oppenheimer 16th Annual Israeli Conference.  The panel will take place on Sunday, May 10, 2015 at 10:15 a.m. Israel time.

Investors and members of the press interested in meeting with Mr. Neev, please contact: Hadas Friedman-Zick, [email protected], +1-03-5167620.

About the Oppenheimer 16th Annual Israeli Conference

The Oppenheimer 16th Annual Israeli Conference will be held at the David Intercontinental Hotel in Tel-Aviv between 8:30 a.m. and 4:00 p.m. More than 50 Israeli companies will present at this year's conference and more than 500 members of the Israeli financial community are expected to attend.

About Check-Cap

Check-Cap is a clinical stage medical diagnostics company focused on the development of gastrointestinal imaging devices. The Company's lead product is an endoscopy capsule with a colon imaging system for colorectal cancer and clinically-significant pre-cancerous polyps that utilizes proprietary, ultra-low-energy X-ray-based measurement technology to safely generate high-resolution, 3-dimensional imagery of the colon without cleansing or other aggressive bowel preparation. This solution is designed to increase compliance with screening recommendations.  The Check-Cap imaging system is not cleared for marketing in any jurisdiction.

Legal Notice Regarding Forward-Looking Statements

This press release contains "forward-looking statements." Words such as "may," "should," "could," "would," "predicts," "potential," "continue," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar expressions, as well as statements in future tense, often signify forward-looking statements.  Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved.  Forward-looking statements are based on information that the Company has when those statements are made or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.  For a discussion of these and other risks that could cause such differences and that may affect the realization of forward-looking statements, please refer to the "Special Note On Forward-looking Statements" and "Risk Factors" in the Company's Registration Statement on Form F-1 and other filings with the Securities and Exchange Commission (SEC). Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.  The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

CONTACT:

Investors (Israel)
Hadas Friedman-Zick
KM Investor Relations
[email protected]

Investors (U.S.)
David Carey
Lazar Partners Ltd.
212-867-1768
[email protected]

SOURCE Check-Cap, Ltd.